SDIX™ (NASDAQ: SDIX) reached up 50.81% in morning trading to $2.805 with 1M shares traded. SDIX is a biotechnology company delivering advanced immuno-solutions and critical reagents to the life science sector, including pharmaceutical, biotechnology, diagnostic, and basic research partners as well as effective pathogen detection tests to help ensure food safety. SDIX™ (NASDAQ:SDIX - News) today announced that its RapidChek® SELECT™ Salmonella Enteritidis (SE) test system has been reviewed by the U.S. Food and Drug Administration (FDA) and determined to be equivalent in accuracy, precision and sensitivity to their current standard methods for poultry house environmental drag swabs and pooled egg testing. For pooled egg testing, SDIX’s method is considered by FDA as equivalent to its standard test without a 96-hour hold period, thus delivering results with a substantial time and cost advantage.
Fibrocell Science, Inc. (OTCBB: FCSC) reached up 25% in morning trading to $.75 with 800K shares traded. Fibrocell Science, Inc. is a biotechnology company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications. Fibrocell Science is committed to advancing the scientific, medical and commercial potential of autologous skin and tissue, as well its innovative cellular processing technology and manufacturing excellence. Fibrocell Science, Inc. (OTCBB:FCSC.ob - News) announced today that the U.S. Food & Drug Administration (FDA) has accepted for review the Company’s complete response submission for azficel-T, proposed brand name laViv®, for the treatment of moderate to severe nasolabial folds and wrinkles. The Prescription Drug User Fee Act (PDUFA) date is June 22, 2011.
China Direct Industries, Inc. (NASDAQ:CDII) reached up 12.75% in morning trading to $1.68 with 2M shares traded. China Direct Industries, Inc. is a U.S. owned holding company operating in China in two core business segments, pure magnesium production and distribution and distribution of basic materials in China. China Direct Industries also provides advisory services to China based companies in competing in the global economy. Headquartered in Deerfield Beach, Florida, China Direct Industries operates 9 subsidiaries throughout China. This infrastructure creates a platform to expand business opportunities globally while effectively and efficiently accessing the U.S. capital markets. China Direct Industries, Inc. ("China Direct Industries") (NASDAQ:CDII - News) announced today that its magnesium segment operations received new purchase contracts valued at approximately $31 million in its first quarter of fiscal 2011, ended December 31, 2010. Deliveries of these new orders began in the first quarter of fiscal 2011 and are expected to be completed by the third quarter of fiscal 2011.
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE
